Gadobenate dimeglumine (BOPTA) enhanced MR imaging: patterns of enhancement in normal liver and cirrhosis.

Abstract

To determine whether gadobenate dimeglumine (BOPTA) will adequately enhance cirrhotic liver parenchyma, and to document the enhancement patterns in cirrhosis, 14 cirrhotic and 20 non-cirrhotic patients were evaluated before and 60-120 minutes after gadolinium-BOPTA. Proof of liver cirrhosis was biopsy (6), surgical resection (3), and clinical follow-up (5… (More)

Topics

Cite this paper

@article{Manfredi1998GadobenateD, title={Gadobenate dimeglumine (BOPTA) enhanced MR imaging: patterns of enhancement in normal liver and cirrhosis.}, author={Riccardo M. Manfredi and Giulia Maresca and Richard Baron and A. De Franco and Anna Maria De Gaetano and Antonio Raffaele Cotroneo and Gianpaolo Pirovano and Alberto Spinazzi and Pasquale Marano}, journal={Journal of magnetic resonance imaging : JMRI}, year={1998}, volume={8 4}, pages={862-7} }